期刊:Science Translational Medicine [American Association for the Advancement of Science (AAAS)] 日期:2015-09-23卷期号:7 (306)被引量:1
标识
DOI:10.1126/scitranslmed.aad3623
摘要
A clinical trial comparing precision cancer medicine (treatment based on tumor mutations) to standard care did not show survival benefit to precision medicine.